Tech Company Financing Transactions
Cytonics Funding Round
StartEngine participated in a $24 million Series A capital raise for Cytonics. The funding round was recorded on 3/25/2025.
Transaction Overview
Company Name
Announced On
3/25/2025
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
658 West Indiantown Rd. 214
Jupiter, FL 33458
USA
Jupiter, FL 33458
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Cytonics is a biotechnology research and development company that specializes in developing diagnostics and therapeutics for osteoarthritis. Our flagship product was the Fibronectin-Aggrecan Complex Test ("FACT�"), which can detect cartilage damage due to osteoarthritis from samples of patients' joint fluid. We licensed FACT� to Synthes (acquired by Johnson & Johnson) in 2011, and it has been used by hundreds of physicians to diagnose and direct patients' course of treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joey Bose
Browse more venture capital transactions:
Prev: 3/25/2025: Certiverse venture capital transaction
Next: 3/25/2025: Pizza Wings venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs